Temozolomide induces activation of Wnt/beta-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy

Tomar, Vivek Singh and Patil, Vikas and Somasundaram, Kumaravel (2019) Temozolomide induces activation of Wnt/beta-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. In: CELL BIOLOGY AND TOXICOLOGY .

	PDF Cel_Bio_Tox.pdf - Published Version Restricted to Registered users only Download (931kB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS1.pptx - Published Supplemental Material Restricted to Registered users only Download (244kB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS2.pptx - Published Supplemental Material Restricted to Registered users only Download (10MB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS3.pptx - Published Supplemental Material Restricted to Registered users only Download (90kB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS4.pptx - Published Supplemental Material Restricted to Registered users only Download (138kB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS5.pptx - Published Supplemental Material Restricted to Registered users only Download (331kB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS6.pptx - Published Supplemental Material Restricted to Registered users only Download (263kB) | Request a copy
	Microsoft PowerPoint Cel_Bio_ToxS7.pptx - Published Supplemental Material Restricted to Registered users only Download (201kB) | Request a copy
	Microsoft Word Cel_Bio_ToxS8.docx - Published Supplemental Material Restricted to Registered users only Download (25kB) | Request a copy
	Microsoft Excel Cel_Bio_ToxS9.xls - Published Supplemental Material Restricted to Registered users only Download (882kB) | Request a copy
	Microsoft Excel Cel_Bio_ToxS10.xls - Published Supplemental Material Restricted to Registered users only Download (93kB) | Request a copy
	Microsoft Excel Cel_Bio_ToxS11.xls - Published Supplemental Material Restricted to Registered users only Download (27kB) | Request a copy

Abstract

Glioblastoma (GBM) is the most aggressive type of glioma. Temozolomide (TMZ) is currently the drug of choice used for post-operative chemotherapy of GBM. However, the presence of intrinsic and acquired resistance hinders the success of chemotherapy. To understand the TMZ resistant mechanisms in glioma, we investigated the alterations in cellular signaling pathways by performing transcriptome analysis of TMZ treated glioma cells. Gene Set Enrichment Analysis (GSEA) indicated a significant enrichment of Wnt/beta-catenin signaling besides many other pathways in TMZ treated cells. Further, we demonstrate that TMZ treatment increased the activity from TOPflash reporter, (a Wnt responsive reporter), enhanced the levels of pGSK-3 beta (S9) and reduced the levels of p-beta-catenin (S33/37/T41) with a concomitant increase in transcript and protein levels of Wnt targets in a concentration and time-dependent manner. While TMZ treated cells did not show alteration in any of the Wnt ligands, PI3K inhibitor (LY294002) treatment repressed Akt activation and abolished the TMZ-mediated induction of Wnt/beta-catenin pathway. In addition, we show that Wnt/beta-catenin signaling activation by TMZ is independent of ATM/Chk2 pathway. Further, we also demonstrate the activation of mTOR pathway after TMZ treatment. Thus, our results demonstrate that activation of Wnt/beta-catenin pathway involves an ATM/Chk2- independent PI3K/Akt/GSK-3 cascade in TMZ treated cells and further provides mechanistic basis for the chemoresistance of glioma to TMZ.

Item Type:	Journal Article
Publication:	CELL BIOLOGY AND TOXICOLOGY
Publisher:	SPRINGER
Additional Information:	Copyright of this article belongs to SPRINGER
Keywords:	Glioblastoma; Microarray; Temozolomide; Transcriptome; Resistance
Department/Centre:	Division of Biological Sciences > Microbiology & Cell Biology
Date Deposited:	17 Dec 2019 07:51
Last Modified:	17 Dec 2019 07:51
URI:	http://eprints.iisc.ac.in/id/eprint/64043

Actions (login required)

View Item